The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Strongyloides stercoralis hyperinfection (w/wo DAH)
Publications
Fatal strongyloidiasis after corticosteroid therapy for presumed chronic obstructive pulmonary disease.
JMM case reports. 2018;5(9):e005165
Martinez-Perez A, Roure Díez S, Belhassen-Garcia M, Torrús-Tendero D, Perez-Arellano JL, Cabezas T, Soler C, Díaz-Menéndez M, Navarro M, Treviño B, Salvador F, Soil-Transmitted Helminths’ Study Group of the Spanish Society of Tropical Medicine and Interna
Management of severe strongyloidiasis attended at reference centers in Spain.
PLoS neglected tropical diseases. 2018;12(2):e0006272
Parasites of the air passages.
Chest. 2014;145(4):883-895
Images in clinical medicine. Strongyloides stercoralis hyperinfection.
The New England journal of medicine. 2008;359(11):e12
An unusual cause of pulmonary haemorrhage in a patient with rheumatoid arthritis.
Annals of the Academy of Medicine, Singapore. 2004;33(3):365-7